Search details
1.
A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients.
Cancer Cell Int
; 19: 243, 2019.
Article
in English
| MEDLINE | ID: mdl-31572060
2.
Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer.
World J Gastrointest Surg
; 15(3): 346-361, 2023 Mar 27.
Article
in English
| MEDLINE | ID: mdl-37032802
3.
Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies.
MedComm (2020)
; 4(4): e333, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37502611
4.
An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cancer Med
; 12(7): 8924-8936, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36629124
5.
A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer.
Front Oncol
; 12: 902974, 2022.
Article
in English
| MEDLINE | ID: mdl-35847938
6.
Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer.
Front Genet
; 13: 880093, 2022.
Article
in English
| MEDLINE | ID: mdl-35646105
7.
DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients.
Front Genet
; 13: 872238, 2022.
Article
in English
| MEDLINE | ID: mdl-35495147
8.
Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature.
Front Genet
; 13: 993714, 2022.
Article
in English
| MEDLINE | ID: mdl-36159987
9.
A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer.
Front Mol Biosci
; 7: 613918, 2020.
Article
in English
| MEDLINE | ID: mdl-33490106
Results
1 -
9
de 9
1
Next >
>>